These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21940621)

  • 1. Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism.
    Pappatà S; Santangelo G; Aarsland D; Vicidomini C; Longo K; Bronnick K; Amboni M; Erro R; Vitale C; Caprio MG; Pellecchia MT; Brunetti A; De Michele G; Salvatore M; Barone P
    Neurology; 2011 Oct; 77(14):1357-62. PubMed ID: 21940621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal study of cognitive and cerebral metabolic changes in Parkinson's disease.
    Baba T; Hosokai Y; Nishio Y; Kikuchi A; Hirayama K; Suzuki K; Hasegawa T; Aoki M; Takeda A; Mori E
    J Neurol Sci; 2017 Jan; 372():288-293. PubMed ID: 28017230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment.
    Lyoo CH; Jeong Y; Ryu YH; Rinne JO; Lee MS
    Eur Neurol; 2010; 64(2):65-73. PubMed ID: 20606450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson's Disease.
    Tang Y; Ge J; Liu F; Wu P; Guo S; Liu Z; Wang Y; Wang Y; Ding Z; Wu J; Zuo C; Wang J
    PLoS One; 2016; 11(4):e0152716. PubMed ID: 27064684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive profile and 18F-fluorodeoxyglucose PET study in LRRK2-related Parkinson's disease.
    De Rosa A; Peluso S; De Lucia N; Russo P; Annarumma I; Esposito M; Manganelli F; Brunetti A; De Michele G; Pappatà S
    Parkinsonism Relat Disord; 2018 Feb; 47():80-83. PubMed ID: 29249679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
    Drzezga A; Lautenschlager N; Siebner H; Riemenschneider M; Willoch F; Minoshima S; Schwaiger M; Kurz A
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1104-13. PubMed ID: 12764551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease.
    Garcia-Garcia D; Clavero P; Gasca Salas C; Lamet I; Arbizu J; Gonzalez-Redondo R; Obeso JA; Rodriguez-Oroz MC
    Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1767-77. PubMed ID: 22872307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration-[18F]FDG-PET.
    Liepelt I; Reimold M; Maetzler W; Godau J; Reischl G; Gaenslen A; Herbst H; Berg D
    Mov Disord; 2009 Jul; 24(10):1504-11. PubMed ID: 19489069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of cerebral glucose metabolism in patients with cognitive impairment in Parkinson's disease].
    Homenko JG; Susin DS; Kataeva GV; Irishina JA; Zavolokov IG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):46-51. PubMed ID: 28638030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Statistical parametric mapping analysis of
    Chu JS; Liu TH; Zang YZ; Wang KL; Ma HZ; Han CL; Zhao XB; Liu YP; Xia XT; Meng FG
    Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(33):2632-2635. PubMed ID: 30220149
    [No Abstract]   [Full Text] [Related]  

  • 11. Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment.
    Gasca-Salas C; Clavero P; García-García D; Obeso JA; Rodríguez-Oroz MC
    Hum Brain Mapp; 2016 Mar; 37(3):968-77. PubMed ID: 26663702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study.
    Bohnen NI; Koeppe RA; Minoshima S; Giordani B; Albin RL; Frey KA; Kuhl DE
    J Nucl Med; 2011 Jun; 52(6):848-55. PubMed ID: 21571793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease.
    Huang C; Mattis P; Perrine K; Brown N; Dhawan V; Eidelberg D
    Neurology; 2008 Apr; 70(16 Pt 2):1470-7. PubMed ID: 18367705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment.
    Albin RL; Koeppe RA; Burke JF; Giordani B; Kilbourn MR; Gilman S; Frey KA
    Arch Neurol; 2010 Apr; 67(4):440-6. PubMed ID: 20385910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between cognitive deficits and glucose hypometabolism in mild cognitive impairment.
    Nishi H; Sawamoto N; Namiki C; Yoshida H; Dinh HD; Ishizu K; Hashikawa K; Fukuyama H
    J Neuroimaging; 2010 Jan; 20(1):29-36. PubMed ID: 19018949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease.
    Winer JR; Maass A; Pressman P; Stiver J; Schonhaut DR; Baker SL; Kramer J; Rabinovici GD; Jagust WJ
    JAMA Neurol; 2018 Feb; 75(2):227-235. PubMed ID: 29228071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amnestic mild cognitive impairment in Parkinson's disease: a brain perfusion SPECT study.
    Nobili F; Abbruzzese G; Morbelli S; Marchese R; Girtler N; Dessi B; Brugnolo A; Canepa C; Drosos GC; Sambuceti G; Rodriguez G
    Mov Disord; 2009 Feb; 24(3):414-21. PubMed ID: 19235928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD).
    Nobili F; Morbelli S; Arnaldi D; Ferrara M; Campus C; Brugnolo A; Mazzei D; Mehrdad N; Sambuceti G; Rodriguez G
    J Neurol Sci; 2011 Nov; 310(1-2):31-5. PubMed ID: 21762928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration patterns of brain glucose metabolism: comparisons of healthy controls, subjective memory impairment and mild cognitive impairment.
    Song IU; Choi EK; Oh JK; Chung YA; Chung SW
    Acta Radiol; 2016 Jan; 57(1):90-7. PubMed ID: 25538106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical image analysis of cerebral glucose metabolism in patients with cognitive impairment following diffuse traumatic brain injury.
    Kato T; Nakayama N; Yasokawa Y; Okumura A; Shinoda J; Iwama T
    J Neurotrauma; 2007 Jun; 24(6):919-26. PubMed ID: 17600509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.